Latest stories on OCUL
Ocular Therapeutix GAAP EPS of -$0.35 beats by $0.04, revenue of $13.48M beats by $0.28M
Seeking Alpha63 · neutralearnings
OCULAR THERAPEUTIX, INC (OCUL) files 8-K
SEC 8-K50 · neutralgeneral
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
StockTitan50 · neutralearnings
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OCUL Stock News
StockTitan50 · neutralgeneral
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences | OCUL Stock News
StockTitan56 · neutralproduct/pr
Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?
Yahoo Top63 · neutralanalyst
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OCUL Stock News
StockTitan50 · neutralgeneral
Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day Transcript
Seeking Alpha55 · neutralgeneral
Ocular Therapeutix, Inc. (OCUL) Analyst/Investor Day - Slideshow
Seeking Alpha50 · neutralgeneral
OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda?
Stocktwits News63 · neutralproduct/pr
Ocular Therapeutix Says FDA Aligned on Application for Axpaxli
Morningstar63 · neutralgeneral
Ocular to submit Axpaxli NDA for wet AMD in Q4
Seeking Alpha67 · bullishproduct/pr
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool54 · neutralanalyst
Ocular Therapeutix Expands Equity Plan and Confirms Leadership
TipRanks24 · bearishgeneral
OCULAR THERAPEUTIX, INC (OCUL) files 8-K
SEC 8-K50 · neutralgeneral
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OCUL Stock News
StockTitan50 · neutralgeneral
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026 | OCUL Stock News
StockTitan56 · neutralgeneral
Ocular Therapeutix™ to Host Investor Day on June 17, 2026 | OCUL Stock News
StockTitan56 · neutralproduct/pr
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1
Yahoo Finance38 · neutralgeneral
Synakis Announces Close of Oversubscribed Pre-Seed Round
PR Newswire58 · neutralgeneral
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
Yahoo Top42 · neutralgeneral